You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 4, January 24/31, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Dermatology
 •Psychiatry
 •Depression
 •Psoriasis
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Psoriasis and Risk of Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Psoriasis is considered an immune-mediated inflammatory disease, such as rheumatoid arthritis or Crohn disease. Dr Gelfand and colleagues1 found psoriasis to be an independent risk factor for MI. This is consistent with similar findings in other immune-mediated inflammatory diseases, such as rheumatoid arthritis,2 and supports the systemic nature of the underlying inflammation. Atherosclerosis is regarded as an inflammatory process as well.3 The cascade of events that ultimately results in formation of atherosclerotic plaques begins with infiltration and retention of low-density lipoprotein and activation of endothelial cells. Platelets are the first blood cells to arrive at the scene, likely contributing to further endothelial activation and subsequent formation of an inflammatory cell infiltrate in the forming plaque.4

The notions of a crucial role of platelets in the formation of atherosclerotic plaques and psoriasis as a systemic inflammatory disease resulting in higher cardiovascular morbidity are supported by the finding that . . . [Full Text of this Article]

Ralf J. Ludwig, MD
r.ludwig@em.uni-frankfurt.de

Wolf-Henning Boehncke, MD
Department of Dermatology
Clinic of the Johann Wolfgang Goethe University
Frankfurt am Main, Germany


RELATED LETTERS

Psoriasis and Risk of Myocardial Infarction
Alevizos Alevizos, Georgios Larios, and Anargiros Mariolis
JAMA. 2007;297(4):361.
EXTRACT | FULL TEXT  

Psoriasis and Risk of Myocardial Infarction
Mario Malerba, Paolo Gisondi, Alessandro Radaeli, and Giampiero Girolomoni
JAMA. 2007;297(4):361-362.
EXTRACT | FULL TEXT  

Psoriasis and Risk of Myocardial Infarction—Reply
Joel M. Gelfand, Shanu Kohli Kurd, Andrea L. Neimann, Daniel B. Shin, David J. Margolis, and Andrea B. Troxel
JAMA. 2007;297(4):362-363.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Risk of Myocardial Infarction in Patients With Psoriasis
Joel M. Gelfand, Andrea L. Neimann, Daniel B. Shin, Xingmei Wang, David J. Margolis, and Andrea B. Troxel
JAMA. 2006;296(14):1735-1741.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.